1. Home
  2. Labeler Index
  3. Hub Pharmaceuticals, Inc.
  4. 17238-920
  5. Label Information: Greenglo

FDA Label for Greenglo

View Indications, Usage & Precautions

Table of Contents

    1. PRODUCT FACTS
    2. INDICATIONS:
    3. DIRECTIONS FOR USE:
    4. NOTE:
    5. HOW SUPPLIED:
    6. REPRESENTATIVE PACKAGING:

Greenglo Product Label

The following document was submitted to the FDA by the labeler of this product Hub Pharmaceuticals, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Product Facts



Each sterile strip is impregnated with 1.5 mg. of Lissamine Green


Indications:



For use as a diagnostic agent when superficial corneal or conjunctival tissue change is suspected.


Directions For Use:



For best viewing and patient comfort, the Lissamine Green impregnated tip should be moistened with one or two drops of sterile irrigating or saline solution before application. Apply moistened tip to conjunctiva or fornix as required. It is recommended that the patient blink several times after application.

1. Hold package in middle and tear down toward sterile strip

2. Turn over and tear down from other side, taking care not to tear the sterile strip.

3. Grasp each end of package firmly as shown, without touching the sterile strip, and pull apart.


Note:



Not to be used with soft contact lenses. For external use only. Keep out of the reach of childred.


How Supplied:



Dispenser carton containing 100 strips.


Representative Packaging:



17238-920-98: GreenGlo individual Strip (above)

17238-920-11: Dispenser Carton containing 100 strips (above)


* Please review the disclaimer below.